Affordable Access

deepdyve-link
Publisher Website

[Advances in the study of mesenchymal stem cells for end-stage liver disease].

Authors
  • Zheng, Y Y1
  • Zhu, S1
  • Peng, L2
  • Gao, Z L2
  • 1 The Third Clinical College of Sun Yat-sen University, Guangzhou 510630, China. , (China)
  • 2 Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. , (China)
Type
Published Article
Journal
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Publication Date
Jul 20, 2021
Volume
29
Issue
7
Pages
618–621
Identifiers
DOI: 10.3760/cma.j.cn501113-20210610-00270
PMID: 34371530
Source
Medline
Keywords
Language
Chinese
License
Unknown

Abstract

终末期肝病指各种慢性肝脏损伤所致的肝病晚期阶段,原位肝移植是最主要的最终治疗方案,但目前肝移植仍受许多因素限制。间充质干细胞作为一类具有自我更新能力的多系祖细胞,具有多向分化、抗凋亡、抗炎、免疫抑制等功能。干细胞移植疗法作为终末期肝病的一种潜在治疗方法普遍受到关注。现就间充质干细胞治疗在终末期肝病中应用的研究进展进行综述。.

Report this publication

Statistics

Seen <100 times